Analytical Data
-
Gene name
PSG7
- Application
-
Alternative Names
PSG7；Pregnancy-specific beta-1-glycoProtein 7
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13046
-
Expression Region
35-419aa
-
AA Sequence
QVTIEAQPPKVSEGKDVLLLVHNLPQNLTGYIWYKGQIRDLYHYVTSYIVDGQIIKYGPAYSGRETVYSNASLLIQNVTQEDTGSYTLHIIKRGDGTGGVTGRFTFTLYLETPKPSISSSNFNPREATEAVILTCDPETPDASYLWWMNGQSLPMTHSLQLSETNRTLYLFGVTNYTAGPYECEIRNPVSASRSDPVTLNLLPKLPKPYITINNLNPRENKDVSTFTCEPKSENYTYIWWLNGQSLPVSPRVKRRIENRILILPSVTRNETGPYQCEIRDRYGGIRSDPVTLNVLYGPDLPRIYPSFTYYHSGQNLYLSCFADSNPPAQYSWTINGKFQLSGQKLSIPQITTKHSGLYACSVRNSATGKESSKSVTVRVSDWTLP
-
Molecular Weight
48.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSG7, or Pregnancy-Specific Glycoprotein 7, is a member of the PSG family of proteins, which are predominantly expressed in the placenta during pregnancy. These proteins play a crucial role in regulating the immune response, influencing maternal tolerance toward the developing fetus, and are implicated in several reproductive processes. The study of PSG7, particularly its recombinant form, has garnered significant interest due to its potential applications in reproductive medicine and immunology. Research has suggested that PSG7 may modulate immune functions by interacting with various immune cells and cytokines, possibly contributing to a favorable environment for fetal development. Understanding the structure-function relationship of PSG7 through recombinant protein studies could unveil its mechanisms of action and lead to novel therapeutic strategies for addressing reproductive challenges, autoimmune disorders, and complications during pregnancy. Consequently, the exploration of recombinant PSG7 not only enhances our understanding of its biological significance but also opens avenues for innovative clinical applications.
